Literature DB >> 24128046

Oridonin ring A-based diverse constructions of enone functionality: identification of novel dienone analogues effective for highly aggressive breast cancer by inducing apoptosis.

Chunyong Ding1, Yusong Zhang, Haijun Chen, Zhengduo Yang, Christopher Wild, Na Ye, Corbin D Ester, Ailian Xiong, Mark A White, Qiang Shen, Jia Zhou.   

Abstract

Oridonin (1) has attracted considerable attention in recent years because of its unique and safe anticancer pharmacological profile. Nevertheless, it exhibits moderate to poor effects against highly aggressive cancers including triple-negative and drug-resistant breast cancer cells. Herein, we report the rational design and synthesis of novel dienone derivatives with an additional α,β-unsaturated ketone system diversely installed in the A-ring based on this class of natural scaffold that features dense functionalities and stereochemistry-rich frameworks. Efficient and regioselective enone construction strategies have been established. Meanwhile, a unique 3,7-rearrangement reaction was identified to furnish an unprecedented dienone scaffold. Intriguingly, these new analogues have been demonstrated to significantly induce apoptosis and inhibit colony formation with superior antitumor effects against aggressive and drug-resistant breast cancer cells in vitro and in vivo while also exhibiting comparable or lower toxicity to normal human mammary epithelial cells in comparison with 1.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24128046      PMCID: PMC3880594          DOI: 10.1021/jm401248x

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  41 in total

Review 1.  Apoptosis, chemoresistance, and breast cancer: insights from the MCF-7 cell model system.

Authors:  Rebecca Simstein; Matthew Burow; Amanda Parker; Christopher Weldon; Barbara Beckman
Journal:  Exp Biol Med (Maywood)       Date:  2003-10

2.  The antitumor and antibacterial activity of the Isodon diterpenoids.

Authors:  E Fujita; Y Nagao; K Kaneko; S Nakazawa; H Kuroda
Journal:  Chem Pharm Bull (Tokyo)       Date:  1976-09       Impact factor: 1.645

3.  Cytotoxicity of sesquiterpene lactones.

Authors:  K H Lee; E S Huang; C Piantadosi; J S Pagano; T A Geissman
Journal:  Cancer Res       Date:  1971-11       Impact factor: 12.701

4.  Degradation and inactivation of antitumor drugs.

Authors:  J A Benvenuto; T H Connor; D K Monteith; J L Laidlaw; S C Adams; T S Matney; J C Theiss
Journal:  J Pharm Sci       Date:  1993-10       Impact factor: 3.534

5.  Antitumor activity of acylated oridonin.

Authors:  E Fujita; Y Nagao; T Kohno; M Matsuda; M Ozaki
Journal:  Chem Pharm Bull (Tokyo)       Date:  1981-11       Impact factor: 1.645

6.  Novel nitrogen-enriched oridonin analogues with thiazole-fused A-ring: protecting group-free synthesis, enhanced anticancer profile, and improved aqueous solubility.

Authors:  Chunyong Ding; Yusong Zhang; Haijun Chen; Zhengduo Yang; Christopher Wild; Lili Chu; Huiling Liu; Qiang Shen; Jia Zhou
Journal:  J Med Chem       Date:  2013-06-19       Impact factor: 7.446

Review 7.  Oridonin: An active diterpenoid targeting cell cycle arrest, apoptotic and autophagic pathways for cancer therapeutics.

Authors:  Chun-yang Li; En-qin Wang; Yan Cheng; Jin-ku Bao
Journal:  Int J Biochem Cell Biol       Date:  2011-02-02       Impact factor: 5.085

8.  Sesquiterpene antitumor agents: inhibitors of cellular metabolism.

Authors:  K H Lee; I H Hall; E C Mar; C O Starnes; S A ElGebaly; T G Waddell; R I HADGRAFT; C G Ruffner; I Weidner
Journal:  Science       Date:  1977-04-29       Impact factor: 47.728

9.  Oridonin induces a caspase-independent but mitochondria- and MAPK-dependent cell death in the murine fibrosarcoma cell line L929.

Authors:  Chun-Ling Zhang; Li-Jun Wu; Shin-ichi Tashiro; Satoshi Onodera; Takashi Ikejima
Journal:  Biol Pharm Bull       Date:  2004-10       Impact factor: 2.233

Review 10.  Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer.

Authors:  Karen T Liby; Mark M Yore; Michael B Sporn
Journal:  Nat Rev Cancer       Date:  2007-04-19       Impact factor: 60.716

View more
  22 in total

1.  Novel hybrids of natural oridonin-bearing nitrogen mustards as potential anticancer drug candidates.

Authors:  Shengtao Xu; Lingling Pei; Chengqian Wang; Yun-Kai Zhang; Dahong Li; Hequan Yao; Xiaoming Wu; Zhe-Sheng Chen; Yijun Sun; Jinyi Xu
Journal:  ACS Med Chem Lett       Date:  2014-05-28       Impact factor: 4.345

2.  Regio- and Stereospecific Synthesis of Oridonin D-Ring Aziridinated Analogues for the Treatment of Triple-Negative Breast Cancer via Mediated Irreversible Covalent Warheads.

Authors:  Ye Ding; Dengfeng Li; Chunyong Ding; Pingyuan Wang; Zhiqing Liu; Eric A Wold; Na Ye; Haiying Chen; Mark A White; Qiang Shen; Jia Zhou
Journal:  J Med Chem       Date:  2018-03-20       Impact factor: 7.446

3.  Microtubule-stabilizing properties of the avocado-derived toxins (+)-(R)-persin and (+)-(R)-tetrahydropersin in cancer cells and activity of related synthetic analogs.

Authors:  Jessica J Field; Arun Kanakkanthara; Darby G Brooke; Saptarshi Sinha; Sushila D Pillai; William A Denny; Alison J Butt; John H Miller
Journal:  Invest New Drugs       Date:  2016-03-12       Impact factor: 3.850

Review 4.  Evolution in medicinal chemistry of ursolic acid derivatives as anticancer agents.

Authors:  Haijun Chen; Yu Gao; Ailan Wang; Xiaobin Zhou; Yunquan Zheng; Jia Zhou
Journal:  Eur J Med Chem       Date:  2015-01-16       Impact factor: 6.514

Review 5.  Therapeutic Potential of Spirooxindoles as Antiviral Agents.

Authors:  Na Ye; Haiying Chen; Eric A Wold; Pei-Yong Shi; Jia Zhou
Journal:  ACS Infect Dis       Date:  2016-05-05       Impact factor: 5.084

Review 6.  Discovery and development of natural product oridonin-inspired anticancer agents.

Authors:  Ye Ding; Chunyong Ding; Na Ye; Zhiqing Liu; Eric A Wold; Haiying Chen; Christopher Wild; Qiang Shen; Jia Zhou
Journal:  Eur J Med Chem       Date:  2016-06-13       Impact factor: 6.514

7.  Oridonin inhibits hepatic stellate cell proliferation and fibrogenesis.

Authors:  Fredrick J Bohanon; Xiaofu Wang; Chunyong Ding; Ye Ding; Geetha L Radhakrishnan; Cristiana Rastellini; Jia Zhou; Ravi S Radhakrishnan
Journal:  J Surg Res       Date:  2014-03-20       Impact factor: 2.192

8.  Enhanced effects of novel oridonin analog CYD0682 for hepatic fibrosis.

Authors:  Fredrick J Bohanon; Xiaofu Wang; Brittany M Graham; Chunyong Ding; Ye Ding; Geetha L Radhakrishnan; Cristiana Rastellini; Jia Zhou; Ravi S Radhakrishnan
Journal:  J Surg Res       Date:  2015-08-05       Impact factor: 2.192

9.  Enhanced anti-fibrogenic effects of novel oridonin derivative CYD0692 in hepatic stellate cells.

Authors:  Fredrick J Bohanon; Xiaofu Wang; Brittany M Graham; Anesh Prasai; Sadhashiva J Vasudevan; Chunyong Ding; Ye Ding; Geetha L Radhakrishnan; Cristiana Rastellini; Jia Zhou; Ravi S Radhakrishnan
Journal:  Mol Cell Biochem       Date:  2015-09-07       Impact factor: 3.396

10.  ent-Kaurane-based regio- and stereoselective inverse electron demand hetero-Diels-Alder reactions: synthesis of dihydropyran-fused diterpenoids.

Authors:  Chunyong Ding; Lili Wang; Haijun Chen; Christopher Wild; Na Ye; Ye Ding; Tianzhi Wang; Mark A White; Qiang Shen; Jia Zhou
Journal:  Org Biomol Chem       Date:  2014-11-14       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.